Physician profile
Mark A Kassels
NPI 1437114055
$2,034.45
in general payments reported to CMS, 2019-2025
13 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $220 · 2021: $333 · 2022: $311 · 2023: $437 · 2024: $334 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,175.02 | 2019-2025 | Tecnis Simplicity, Catalys System, Tecnis Iol |
| Alcon Vision LLC | $445.43 | 2021-2025 | Rocklatan, Clareon, Hydrus Microstent |
| Oyster Point Pharma, INC. | $74.37 | 2023-2024 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $72.03 | 2019-2021 | |
| Abbvie INC. | $66.26 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $38.65 | 2019-2020 | |
| Nova Eye, INC. | $33.32 | 2024-2025 | |
| New World Medical,INC. | $32.30 | 2020-2021 | |
| Alcon Research LLC | $25.77 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.37 | 2021 | |
| Thea Pharma INC. | $19.01 | 2024 | Iyuzeh |
| Sight Sciences, INC. | $16.09 | 2023 | Omni Surgical System |
| Allergan, INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kassels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.